Frontiers in Pharmacology (May 2022)

Promising Role of Emodin as Therapeutics to Against Viral Infections

  • Qingqing Shao,
  • Tong Liu,
  • Wenjia Wang,
  • Tianli Liu,
  • Ximing Jin,
  • Zhuo Chen,
  • Zhuo Chen

DOI
https://doi.org/10.3389/fphar.2022.902626
Journal volume & issue
Vol. 13

Abstract

Read online

Emodin is an anthraquinone derivative that is widely present in natural plants and has a wide spectrum of pharmacological effects, such as antibacterial, anti-inflammatory, anti-fibrotic and anticancer and so on. Through reviewing studies on antiviral effect of emodin in the past decades, we found that emodin exhibits ability of inhibiting the infection and replication of more than 10 viruses in vitro and in vivo, including herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), human cytomegalovirus (HCMV), Epstein-Barr virus (EBV), coxsackievirus B (CVB), hepatitis B virus (HBV), influenza A virus (IAV), SARS-CoV, viral haemorrhagic septicaemia rhabdovirus (VHSV), enterovirus 71 (EV71), dengue virus serotype 2 (DENV-2) and Zika virus (ZIKV). Therefore, this review aims to summarize the antiviral effect of emodin, in order to provide reference and hopes to support the further investigations.

Keywords